Terms: = Lung cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Prognosis
3748 results:
1. Death associated protein kinase 1 predicts the prognosis and the immunotherapy response of various cancers.
Yang J; Liu Y; Geng Q; Wang B
Mol Biol Rep; 2024 May; 51(1):670. PubMed ID: 38787485
[TBL] [Abstract] [Full Text] [Related]
2. Biosensing of Alpha-Fetoprotein: A Key Direction toward the Early Detection and Management of Hepatocellular Carcinoma.
Ramachandran L; Abul Rub F; Hajja A; Alodhaibi I; Arai M; Alfuwais M; Makhzoum T; Yaqinuddin A; Al-Kattan K; Assiri AM; Broering DC; Chinnappan R; Mir TA; Mani NK
Biosensors (Basel); 2024 May; 14(5):. PubMed ID: 38785709
[TBL] [Abstract] [Full Text] [Related]
3. In situ analysis of CCR8
Hayashi Y; Ueyama A; Funaki S; Jinushi K; Higuchi N; Morihara H; Hirata M; Nagira Y; Saito T; Kawashima A; Iwahori K; Shintani Y; Wada H
BMC Cancer; 2024 May; 24(1):627. PubMed ID: 38783281
[TBL] [Abstract] [Full Text] [Related]
4. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
5. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
Zhang T; Chu L; Tan W; Ye C; Dong H
Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
[TBL] [Abstract] [Full Text] [Related]
6. A systematic pan-cancer analysis identifies LDHA as a novel predictor for immunological, prognostic, and immunotherapy resistance.
Zhang Q; Luo Y; Qian B; Cao X; Xu C; Guo K; Wan R; Jiang Y; Wang T; Mei Z; Liu J; Lv C
Aging (Albany NY); 2024 May; 16(9):8000-8018. PubMed ID: 38709280
[TBL] [Abstract] [Full Text] [Related]
7. The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability.
Abad E; Sandoz J; Romero G; Zadra I; Urgel-Solas J; Borredat P; Kourtis S; Ortet L; Martínez CM; Weghorn D; Sdelci S; Janic A
J Exp Clin Cancer Res; 2024 Apr; 43(1):127. PubMed ID: 38685100
[TBL] [Abstract] [Full Text] [Related]
8. [Interpretation of global lung cancer statistics].
Cai L; Zhu CX; Zhang XL; Fang Y; Yang HY; Guo LW
Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Apr; 45(4):585-590. PubMed ID: 38678357
[TBL] [Abstract] [Full Text] [Related]
9. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression.
Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
[TBL] [Abstract] [Full Text] [Related]
10. Curcumin-loaded liposomes modulating the synergistic role of EpCAM and estrogen receptor alpha in lung cancer management.
Singh M; De Rubis G; Kokkinis S; Paudel KR; Yeung S; Hansbro PM; Oliver BGG; Dua K
Pathol Res Pract; 2024 May; 257():155317. PubMed ID: 38657558
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy of Sorafenib-Based Therapies for Non-Small Cell lung cancer.
Hendrixson M; Gladkiy Y; Thyagarajan A; Sahu RP
Med Sci (Basel); 2024 Apr; 12(2):. PubMed ID: 38651414
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of cancer-associated fibroblasts related genes identifies COL11A1 associated with lung adenocarcinoma prognosis.
Zheng H; Tan J; Qin F; Zheng Y; Yang X; Qin X; Liao H
BMC Med Genomics; 2024 Apr; 17(1):97. PubMed ID: 38649961
[TBL] [Abstract] [Full Text] [Related]
13. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD.
Ma C; Gu Z; Yang Y
J Cell Mol Med; 2024 Apr; 28(8):e18282. PubMed ID: 38647237
[TBL] [Abstract] [Full Text] [Related]
14. Targeting KRAS in cancer.
Singhal A; Li BT; O'Reilly EM
Nat Med; 2024 Apr; 30(4):969-983. PubMed ID: 38637634
[TBL] [Abstract] [Full Text] [Related]
15. TIMM17A overexpression in lung adenocarcinoma and its association with prognosis.
Miao L; Wu D; Zhao H; Xie A
Sci Rep; 2024 Apr; 14(1):8840. PubMed ID: 38632467
[TBL] [Abstract] [Full Text] [Related]
16. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
[TBL] [Abstract] [Full Text] [Related]
17. Computational identification and experimental verification of a novel signature based on SARS-CoV-2-related genes for predicting prognosis, immune microenvironment and therapeutic strategies in lung adenocarcinoma patients.
Wang Y; Xu Y; Deng Y; Yang L; Wang D; Yang Z; Zhang Y
Front Immunol; 2024; 15():1366928. PubMed ID: 38601163
[TBL] [Abstract] [Full Text] [Related]
18. A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells.
Fonseca P; Cui W; Struyf N; Tong L; Chaurasiya A; Casagrande F; Zhao H; Fernando D; Chen X; Tobin NP; Seashore-Ludlow B; Lundqvist A; Hartman J; Göndör A; Östling P; Holmgren L
J Exp Clin Cancer Res; 2024 Apr; 43(1):107. PubMed ID: 38594748
[TBL] [Abstract] [Full Text] [Related]
19. NFKBIZ regulates NFκB signaling pathway to mediate tumorigenesis and metastasis of hepatocellular carcinoma by direct interaction with TRIM16.
Guo D; Zhang M; Wei T; Zhang X; Shi X; Tang H; Ding M; Li J; Zhang S; Guo W
Cell Mol Life Sci; 2024 Apr; 81(1):167. PubMed ID: 38581570
[TBL] [Abstract] [Full Text] [Related]
20. Decoding the tumour-modulatory roles of LIMK2.
Chong ZX; Ho WY; Yeap SK
Life Sci; 2024 Jun; 347():122609. PubMed ID: 38580197
[TBL] [Abstract] [Full Text] [Related]
[Next]
